[{"AccountsPayableCurrent_0_Q3_USD":25713000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":5049000.0,"OtherAssetsNoncurrent_0_Q3_USD":3580000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":-4000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":-12000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-4000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":98000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.072,"OtherNonoperatingIncomeExpense_1_Q3_USD":336000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":295279000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":5173000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":2310000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":910000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":307000.0,"OperatingLeasePayments_3_Q3_USD":920000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-212390000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-70300000.0,"NetIncomeLoss_3_Q3_USD":-71514000.0,"NetIncomeLoss_1_Q3_USD":-26615000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-26615000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-71514000.0,"OperatingExpenses_1_Q3_USD":26951000.0,"OperatingExpenses_3_Q3_USD":73824000.0,"OperatingIncomeLoss_1_Q3_USD":-26951000.0,"OperatingIncomeLoss_3_Q3_USD":-73824000.0,"OperatingLeaseExpense_1_Q3_USD":1000000.0,"OperatingLeaseExpense_3_Q3_USD":1900000.0,"OperatingLeaseLiability_0_Q3_USD":1166000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":613000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":553000.0,"PreferredStockValue_0_Q3_USD":null,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":9042000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":24373000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":58000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.005,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":2500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":12400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":62382.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":17.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":14.37,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_3_Q3_shares":62382.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.5,"ShortTermInvestments_0_Q3_USD":166532000.0,"StockholdersEquity_0_Q3_USD":305956000.0,"StockIssued1_3_Q3_USD":10000000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":12120000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":491000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q3_USD":3.91,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.81,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":30062000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1444000.0,"ProfitLoss_3_Q3_USD":-71514000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":12045000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6626000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":20428000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":55337000.0,"RestrictedCashNoncurrent_0_Q3_USD":871000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-270078000.0,"ShareBasedCompensation_3_Q3_USD":7571000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.818,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.825,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.812,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":7108000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51627249.0,"MarketableSecuritiesRealizedGainLoss_3_Q3_USD":2000.0,"LongTermInvestments_0_Q3_USD":39735000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockSharesIssued_0_Q3_shares":52587855.0,"CommonStockSharesOutstanding_0_Q3_shares":52587855.0,"CommonStockValue_0_Q3_USD":56000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-26619000.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-71526000.0,"DepreciationAndAmortization_3_Q3_USD":1300000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1341000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.51,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.39,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":363000.0,"DepreciationAndAmortization_1_Q3_USD":500000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-273285000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":112915000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-910000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":12027000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":643000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":5419000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-12000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":575990000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2937000.0,"Assets_0_Q3_USD":354068000.0,"AssetsCurrent_0_Q3_USD":302949000.0,"AssetsNoncurrent_0_Q3_USD":51119000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":39735000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":166532000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":206267000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":271000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":112044000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2075000.0,"MarketableSecuritiesRealizedGainLoss_1_Q3_USD":1000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":16306000.0,"InterestExpense_3_Q3_USD":7000.0,"InterestPaidNet_3_Q3_USD":7000.0,"InvestmentIncomeInterest_1_Q3_USD":90000.0,"InvestmentIncomeInterest_3_Q3_USD":245000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1399000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":3030000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":487000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":388000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":379000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":233000.0,"Liabilities_0_Q3_USD":48112000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":354068000.0,"LiabilitiesCurrent_0_Q3_USD":47461000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":398000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":8448000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":5601000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-54000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":1393000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":-32000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6523000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":18487000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":52187303.0,"Ticker":"PCVX","CIK":"1649094","name":"VAXCYTE, INC.","OfficialName":"Vaxcyte Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1309224961.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]